10000/Boxes
Canmab 150mg Injection contains trastuzumab and is used to treat HER2-positive breast cancer. It targets specific proteins in cancer cells to inhibit their growth and spread.
Canmab Injection Features:
• Targeted therapy for HER2-positive breast cancer.
• Administered intravenously by healthcare professionals.
• MPart of comprehensive treatment regimens to improve outcomes.
• Monitored closely for potential side effects and treatment response.
Minimum Order | 1 |
Copyright © 2024 Shivrupesh Pharma Private Limited All Rights Reserved.